Insiders who bought US$126.0k worth of 60 Degrees Pharmaceuticals, Inc.'s (NASDAQ:SXTP) stock at an average buy price of US$1.27 over the last year may be disappointed by the recent 24% decrease ...
Enrollment expected to commence Q3 2025. WASHINGTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused ...
60 Degrees Pharmaceuticals (SXTP) has entered into definitive agreements for the purchase and sale of an aggregate of 1,503,500 shares of its common stock at a purchase price of 71.5c per share in ...
WASHINGTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for ...
60 Degrees Pharmaceuticals, Inc. announced the approval of an Investigational Review Board (IRB) for a Phase II clinical study aimed at evaluating the efficacy and safety of tafenoquine ...
WASHINGTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious ...
But Pfaff expects that the Grand Strand will “finally” see a “much-anticipated warm up” early next week and, by Wednesday, temperatures could even reach 60 degrees. On Thursday morning ...